RxDoctor Payments Data

Mark Spitzer, MD

Obstetrics & Gynecology · New Hyde Park, NYNPI 1306819438

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (50.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Merck at 47.6% of the total. Reporting peaked in 2020 at $10,365 and has fallen 75.3% since, to $2,555 in 2022. Among obstetrics & gynecology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,911in general payments, 2019–2025

Across 36 payments — averaging $664.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$11K
  • Gen-probe, Inc.$7K
  • Scynexis, Inc.$4K
  • Hologic Inc$1K
  • Agile Therapeutics, Inc.$158
  • Therapeuticsmd, Inc.$155
  • plus $55 from 2 others
$11,540in research payments, 2019–2025

Across 1 payment — averaging $11,540 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Scynexis, Inc.$12K

What the payments were for

  • Consulting fees$12,05350%
  • Speaking & faculty fees$9,94042%
  • Travel & lodging$1,3346%
  • Food & beverage$5842%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck8$11,384
Gen-probe, Inc.4$6,891
Scynexis, Inc.9$3,955
Hologic Inc1$1,313
Agile Therapeutics, Inc.3$158
Therapeuticsmd, Inc.7$155
AbbVie3$41
Dysis Medical, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,911 in reported general payments places this provider in the 95th percentile of 2,673 obstetrics & gynecology providers in New York.

See all obstetrics & gynecology providers in New York

Medicare billing

Part B allowed, 2024
$105,462
Medicare patients
226
Services billed
953

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pimecrolimus11$3,498
Tacrolimus31$3,119
Clobetasol Propionate69$3,026
Estradiol39$2,892
Gabapentin34$451
Duloxetine Hcl11$315
Amitriptyline Hcl13$244
Nortriptyline Hcl11$215
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip12$212
Triamcinolone Acetonide25$123
Fluconazole26$84

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in New Hyde Park

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →